TCD Royalty Sub LP

General

Total Cases7
Active Cases--
Patents--
TypeOperating Company
Elite Ratings
--
--
--
--

Ratings

Experience
Grade
Trend
DCT
L1
C
PTAB
--
--
--
CAFC
--
--
--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
11/22/24
FINAL Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,749,532 B2; 8,206,740 B2. (mpb) (Entered: 11/22/2024)
11/22/24
SO ORDERED, re [7] Stipulation of Dismissal filed by TCD Royalty Sub LP, Galderma Laboratories, L.P. (CASE CLOSED) Signed by Judge Stephanos Bibas on 11/21/2024. (mpb) (Entered: 11/22/2024)
10/22/24
STIPULATION of Dismissal (without prejudice) - by Galderma Laboratories, L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 10/22/2024)
10/09/24
Case Assigned to Judge Stephanos Bibas of the United States Court of Appeals for the Third Circuit (due to related cases). Please include the initials of the Judge (SB) after the case number on all documents filed. (rjb) (Entered: 10/09/2024)
10/04/24
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,749,532 B2; 8,206,740 B2. (scs) (Entered: 10/04/2024)
10/04/24
Summons Issued as to Macleods Pharma USA, Inc. on 10/4/2024; Macleods Pharmaceuticals Ltd. on 10/4/2024. (Attachments: # [1] Summons Issued)(scs) Modified on 10/4/2024 (scs). (Entered: 10/04/2024)
10/04/24
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Galderma Services Inc. for Galderma Laboratories, L.P.; Corporate Parent DRI Healthcare Trust, Corporate Parent DRI Healthcare Acquisitions LP for TCD Royalty Sub LP filed by Galderma Laboratories, L.P., TCD Royalty Sub LP. (scs) (Entered: 10/04/2024)
10/04/24
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 08/22/2024. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 2/22/2027. (scs) (Entered: 10/04/2024)
10/04/24
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) (Entered: 10/04/2024)
10/04/24
COMPLAINT filed for ANDA/PATENT INFRINGEMENT against Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd. ( Filing fee $ 405, receipt number ADEDC-4515751.) - filed by Galderma Laboratories, L.P., TCD Royalty Sub LP. (Attachments: # [1] Exhibit A-B, # [2] Civil Cover Sheet)(scs) (Entered: 10/04/2024)